Sort   by:  
 Page size 
UnknownAutophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors.
Not available
S-EPMC5241115 | biostudies-literature
UnknownMulti-pronged analysis of pediatric low-grade glioma and ganglioglioma reveals a unique tumor microenvironment associated with BRAF alterations.
Not available
S-EPMC12488260 | biostudies-literature
Unknown'Know thyself' - host factors influencing cancer response to immune checkpoint inhibitors.
Not available
S-EPMC9320825 | biostudies-literature
UnknownDevelopment of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma.
Not available
S-EPMC12588558 | biostudies-literature
UnknownA gut microbial signature for combination immune checkpoint blockade across cancer types.
Not available
S-EPMC10957475 | biostudies-literature
UnknownTwo phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Not available
S-EPMC4159618 | biostudies-literature
UnknownAntibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab.
Not available
S-EPMC8927425 | biostudies-literature
UnknownFactors associated with D-dimer levels in HIV-infected individuals.
Not available
S-EPMC3953205 | biostudies-literature
UnknownNeutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study.
Not available
S-EPMC9757903 | biostudies-literature
UnknownIncorporating Concomitant Medications into Genome-Wide Analyses for the Study of Complex Disease and Drug Response.
Not available
S-EPMC5013254 | biostudies-literature
Sort   by:  
 Page size